Global Gastrointestinal OTC Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Gastrointestinal OTC Drugs market size was valued at USD 6071.5 million in 2023 and is forecast to a readjusted size of USD 8639.3 million by 2030 with a CAGR of 5.2% during review period.
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The Global Info Research report includes an overview of the development of the Gastrointestinal OTC Drugs industry chain, the market status of Hospital Pharmacies (Laxatives, Anti-Flatulents), Retail Pharmacies (Laxatives, Anti-Flatulents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal OTC Drugs.
Regionally, the report analyzes the Gastrointestinal OTC Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal OTC Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal OTC Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal OTC Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Laxatives, Anti-Flatulents).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal OTC Drugs market.
Regional Analysis: The report involves examining the Gastrointestinal OTC Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal OTC Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal OTC Drugs:
Company Analysis: Report covers individual Gastrointestinal OTC Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal OTC Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal OTC Drugs. It assesses the current state, advancements, and potential future developments in Gastrointestinal OTC Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal OTC Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal OTC Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Gastrointestinal OTC Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal OTC Drugs, with price, sales, revenue and global market share of Gastrointestinal OTC Drugs from 2019 to 2024.
Chapter 3, the Gastrointestinal OTC Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal OTC Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gastrointestinal OTC Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal OTC Drugs.
Chapter 14 and 15, to describe Gastrointestinal OTC Drugs sales channel, distributors, customers, research findings and conclusion.
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The Global Info Research report includes an overview of the development of the Gastrointestinal OTC Drugs industry chain, the market status of Hospital Pharmacies (Laxatives, Anti-Flatulents), Retail Pharmacies (Laxatives, Anti-Flatulents), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gastrointestinal OTC Drugs.
Regionally, the report analyzes the Gastrointestinal OTC Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gastrointestinal OTC Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Gastrointestinal OTC Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gastrointestinal OTC Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Laxatives, Anti-Flatulents).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gastrointestinal OTC Drugs market.
Regional Analysis: The report involves examining the Gastrointestinal OTC Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gastrointestinal OTC Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Gastrointestinal OTC Drugs:
Company Analysis: Report covers individual Gastrointestinal OTC Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gastrointestinal OTC Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Gastrointestinal OTC Drugs. It assesses the current state, advancements, and potential future developments in Gastrointestinal OTC Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gastrointestinal OTC Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Gastrointestinal OTC Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Laxatives
- Anti-Flatulents
- H2-Antaginists
- Anti-Diarrheals
- PPIs
- Anti-Emetics
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- GlaxoSmithKline
- Pfizer
- Johnson & Johnson
- Bayer
- Procter & Gamble
- Perrigo
- Abbott
- Sanofi
- Teva Pharmaceutical
- Nestle
- Boehringer Ingelheim
- Reckitt Benckiser
- Purdue Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Gastrointestinal OTC Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal OTC Drugs, with price, sales, revenue and global market share of Gastrointestinal OTC Drugs from 2019 to 2024.
Chapter 3, the Gastrointestinal OTC Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal OTC Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gastrointestinal OTC Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal OTC Drugs.
Chapter 14 and 15, to describe Gastrointestinal OTC Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gastrointestinal OTC Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Laxatives
1.3.3 Anti-Flatulents
1.3.4 H2-Antaginists
1.3.5 Anti-Diarrheals
1.3.6 PPIs
1.3.7 Anti-Emetics
1.3.8 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Gastrointestinal OTC Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Gastrointestinal OTC Drugs Market Size & Forecast
1.5.1 Global Gastrointestinal OTC Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Gastrointestinal OTC Drugs Sales Quantity (2019-2030)
1.5.3 Global Gastrointestinal OTC Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
2.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Gastrointestinal OTC Drugs Product and Services
2.2.4 Pfizer Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
2.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Gastrointestinal OTC Drugs Product and Services
2.4.4 Bayer Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments/Updates
2.5 Procter & Gamble
2.5.1 Procter & Gamble Details
2.5.2 Procter & Gamble Major Business
2.5.3 Procter & Gamble Gastrointestinal OTC Drugs Product and Services
2.5.4 Procter & Gamble Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Procter & Gamble Recent Developments/Updates
2.6 Perrigo
2.6.1 Perrigo Details
2.6.2 Perrigo Major Business
2.6.3 Perrigo Gastrointestinal OTC Drugs Product and Services
2.6.4 Perrigo Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Perrigo Recent Developments/Updates
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Gastrointestinal OTC Drugs Product and Services
2.7.4 Abbott Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Gastrointestinal OTC Drugs Product and Services
2.8.4 Sanofi Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
2.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Pharmaceutical Recent Developments/Updates
2.10 Nestle
2.10.1 Nestle Details
2.10.2 Nestle Major Business
2.10.3 Nestle Gastrointestinal OTC Drugs Product and Services
2.10.4 Nestle Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nestle Recent Developments/Updates
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
2.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Boehringer Ingelheim Recent Developments/Updates
2.12 Reckitt Benckiser
2.12.1 Reckitt Benckiser Details
2.12.2 Reckitt Benckiser Major Business
2.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
2.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Reckitt Benckiser Recent Developments/Updates
2.13 Purdue Pharma
2.13.1 Purdue Pharma Details
2.13.2 Purdue Pharma Major Business
2.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product and Services
2.13.4 Purdue Pharma Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Purdue Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GASTROINTESTINAL OTC DRUGS BY MANUFACTURER
3.1 Global Gastrointestinal OTC Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Gastrointestinal OTC Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Gastrointestinal OTC Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Gastrointestinal OTC Drugs Manufacturer Market Share in 2023
3.5 Gastrointestinal OTC Drugs Market: Overall Company Footprint Analysis
3.5.1 Gastrointestinal OTC Drugs Market: Region Footprint
3.5.2 Gastrointestinal OTC Drugs Market: Company Product Type Footprint
3.5.3 Gastrointestinal OTC Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Gastrointestinal OTC Drugs Market Size by Region
4.1.1 Global Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Gastrointestinal OTC Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Gastrointestinal OTC Drugs Average Price by Region (2019-2030)
4.2 North America Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.3 Europe Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.5 South America Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Gastrointestinal OTC Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
5.2 Global Gastrointestinal OTC Drugs Consumption Value by Type (2019-2030)
5.3 Global Gastrointestinal OTC Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
6.2 Global Gastrointestinal OTC Drugs Consumption Value by Application (2019-2030)
6.3 Global Gastrointestinal OTC Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
7.2 North America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
7.3 North America Gastrointestinal OTC Drugs Market Size by Country
7.3.1 North America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Gastrointestinal OTC Drugs Market Size by Country
8.3.1 Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Gastrointestinal OTC Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
10.2 South America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
10.3 South America Gastrointestinal OTC Drugs Market Size by Country
10.3.1 South America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Gastrointestinal OTC Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Gastrointestinal OTC Drugs Market Drivers
12.2 Gastrointestinal OTC Drugs Market Restraints
12.3 Gastrointestinal OTC Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Gastrointestinal OTC Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gastrointestinal OTC Drugs
13.3 Gastrointestinal OTC Drugs Production Process
13.4 Gastrointestinal OTC Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gastrointestinal OTC Drugs Typical Distributors
14.3 Gastrointestinal OTC Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Gastrointestinal OTC Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Laxatives
1.3.3 Anti-Flatulents
1.3.4 H2-Antaginists
1.3.5 Anti-Diarrheals
1.3.6 PPIs
1.3.7 Anti-Emetics
1.3.8 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Gastrointestinal OTC Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Gastrointestinal OTC Drugs Market Size & Forecast
1.5.1 Global Gastrointestinal OTC Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Gastrointestinal OTC Drugs Sales Quantity (2019-2030)
1.5.3 Global Gastrointestinal OTC Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
2.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Gastrointestinal OTC Drugs Product and Services
2.2.4 Pfizer Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
2.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Gastrointestinal OTC Drugs Product and Services
2.4.4 Bayer Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments/Updates
2.5 Procter & Gamble
2.5.1 Procter & Gamble Details
2.5.2 Procter & Gamble Major Business
2.5.3 Procter & Gamble Gastrointestinal OTC Drugs Product and Services
2.5.4 Procter & Gamble Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Procter & Gamble Recent Developments/Updates
2.6 Perrigo
2.6.1 Perrigo Details
2.6.2 Perrigo Major Business
2.6.3 Perrigo Gastrointestinal OTC Drugs Product and Services
2.6.4 Perrigo Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Perrigo Recent Developments/Updates
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Gastrointestinal OTC Drugs Product and Services
2.7.4 Abbott Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Abbott Recent Developments/Updates
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Gastrointestinal OTC Drugs Product and Services
2.8.4 Sanofi Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sanofi Recent Developments/Updates
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
2.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Pharmaceutical Recent Developments/Updates
2.10 Nestle
2.10.1 Nestle Details
2.10.2 Nestle Major Business
2.10.3 Nestle Gastrointestinal OTC Drugs Product and Services
2.10.4 Nestle Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nestle Recent Developments/Updates
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
2.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Boehringer Ingelheim Recent Developments/Updates
2.12 Reckitt Benckiser
2.12.1 Reckitt Benckiser Details
2.12.2 Reckitt Benckiser Major Business
2.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
2.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Reckitt Benckiser Recent Developments/Updates
2.13 Purdue Pharma
2.13.1 Purdue Pharma Details
2.13.2 Purdue Pharma Major Business
2.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product and Services
2.13.4 Purdue Pharma Gastrointestinal OTC Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Purdue Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: GASTROINTESTINAL OTC DRUGS BY MANUFACTURER
3.1 Global Gastrointestinal OTC Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Gastrointestinal OTC Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Gastrointestinal OTC Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Gastrointestinal OTC Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Gastrointestinal OTC Drugs Manufacturer Market Share in 2023
3.5 Gastrointestinal OTC Drugs Market: Overall Company Footprint Analysis
3.5.1 Gastrointestinal OTC Drugs Market: Region Footprint
3.5.2 Gastrointestinal OTC Drugs Market: Company Product Type Footprint
3.5.3 Gastrointestinal OTC Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Gastrointestinal OTC Drugs Market Size by Region
4.1.1 Global Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Gastrointestinal OTC Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Gastrointestinal OTC Drugs Average Price by Region (2019-2030)
4.2 North America Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.3 Europe Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.5 South America Gastrointestinal OTC Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Gastrointestinal OTC Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
5.2 Global Gastrointestinal OTC Drugs Consumption Value by Type (2019-2030)
5.3 Global Gastrointestinal OTC Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
6.2 Global Gastrointestinal OTC Drugs Consumption Value by Application (2019-2030)
6.3 Global Gastrointestinal OTC Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
7.2 North America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
7.3 North America Gastrointestinal OTC Drugs Market Size by Country
7.3.1 North America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Gastrointestinal OTC Drugs Market Size by Country
8.3.1 Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Gastrointestinal OTC Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
10.2 South America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
10.3 South America Gastrointestinal OTC Drugs Market Size by Country
10.3.1 South America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Gastrointestinal OTC Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Gastrointestinal OTC Drugs Market Drivers
12.2 Gastrointestinal OTC Drugs Market Restraints
12.3 Gastrointestinal OTC Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Gastrointestinal OTC Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Gastrointestinal OTC Drugs
13.3 Gastrointestinal OTC Drugs Production Process
13.4 Gastrointestinal OTC Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Gastrointestinal OTC Drugs Typical Distributors
14.3 Gastrointestinal OTC Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Gastrointestinal OTC Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal OTC Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
Table 6. GlaxoSmithKline Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Gastrointestinal OTC Drugs Product and Services
Table 11. Pfizer Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
Table 16. Johnson & Johnson Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Gastrointestinal OTC Drugs Product and Services
Table 21. Bayer Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bayer Recent Developments/Updates
Table 23. Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table 24. Procter & Gamble Major Business
Table 25. Procter & Gamble Gastrointestinal OTC Drugs Product and Services
Table 26. Procter & Gamble Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Procter & Gamble Recent Developments/Updates
Table 28. Perrigo Basic Information, Manufacturing Base and Competitors
Table 29. Perrigo Major Business
Table 30. Perrigo Gastrointestinal OTC Drugs Product and Services
Table 31. Perrigo Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Perrigo Recent Developments/Updates
Table 33. Abbott Basic Information, Manufacturing Base and Competitors
Table 34. Abbott Major Business
Table 35. Abbott Gastrointestinal OTC Drugs Product and Services
Table 36. Abbott Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Abbott Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Gastrointestinal OTC Drugs Product and Services
Table 41. Sanofi Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Major Business
Table 45. Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
Table 46. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Teva Pharmaceutical Recent Developments/Updates
Table 48. Nestle Basic Information, Manufacturing Base and Competitors
Table 49. Nestle Major Business
Table 50. Nestle Gastrointestinal OTC Drugs Product and Services
Table 51. Nestle Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Nestle Recent Developments/Updates
Table 53. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 54. Boehringer Ingelheim Major Business
Table 55. Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
Table 56. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 59. Reckitt Benckiser Major Business
Table 60. Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
Table 61. Reckitt Benckiser Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Reckitt Benckiser Recent Developments/Updates
Table 63. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Purdue Pharma Major Business
Table 65. Purdue Pharma Gastrointestinal OTC Drugs Product and Services
Table 66. Purdue Pharma Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Purdue Pharma Recent Developments/Updates
Table 68. Global Gastrointestinal OTC Drugs Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 69. Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Gastrointestinal OTC Drugs Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 71. Market Position of Manufacturers in Gastrointestinal OTC Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Gastrointestinal OTC Drugs Production Site of Key Manufacturer
Table 73. Gastrointestinal OTC Drugs Market: Company Product Type Footprint
Table 74. Gastrointestinal OTC Drugs Market: Company Product Application Footprint
Table 75. Gastrointestinal OTC Drugs New Market Entrants and Barriers to Market Entry
Table 76. Gastrointestinal OTC Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 78. Global Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 79. Global Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Gastrointestinal OTC Drugs Average Price by Region (2019-2024) & (USD/Dose)
Table 82. Global Gastrointestinal OTC Drugs Average Price by Region (2025-2030) & (USD/Dose)
Table 83. Global Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 84. Global Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 85. Global Gastrointestinal OTC Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Gastrointestinal OTC Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Gastrointestinal OTC Drugs Average Price by Type (2019-2024) & (USD/Dose)
Table 88. Global Gastrointestinal OTC Drugs Average Price by Type (2025-2030) & (USD/Dose)
Table 89. Global Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 90. Global Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 91. Global Gastrointestinal OTC Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Gastrointestinal OTC Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Gastrointestinal OTC Drugs Average Price by Application (2019-2024) & (USD/Dose)
Table 94. Global Gastrointestinal OTC Drugs Average Price by Application (2025-2030) & (USD/Dose)
Table 95. North America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 96. North America Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 97. North America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 98. North America Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 99. North America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 100. North America Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 101. North America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 104. Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 105. Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 106. Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 107. Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 108. Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 109. Europe Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 112. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 113. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 114. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 115. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 116. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 117. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 120. South America Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 121. South America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 122. South America Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 123. South America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 124. South America Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 125. South America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 128. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 129. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 130. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 131. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 132. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 133. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Gastrointestinal OTC Drugs Raw Material
Table 136. Key Manufacturers of Gastrointestinal OTC Drugs Raw Materials
Table 137. Gastrointestinal OTC Drugs Typical Distributors
Table 138. Gastrointestinal OTC Drugs Typical Customers
Table 1. Global Gastrointestinal OTC Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Gastrointestinal OTC Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
Table 6. GlaxoSmithKline Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Gastrointestinal OTC Drugs Product and Services
Table 11. Pfizer Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
Table 16. Johnson & Johnson Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Gastrointestinal OTC Drugs Product and Services
Table 21. Bayer Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bayer Recent Developments/Updates
Table 23. Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table 24. Procter & Gamble Major Business
Table 25. Procter & Gamble Gastrointestinal OTC Drugs Product and Services
Table 26. Procter & Gamble Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Procter & Gamble Recent Developments/Updates
Table 28. Perrigo Basic Information, Manufacturing Base and Competitors
Table 29. Perrigo Major Business
Table 30. Perrigo Gastrointestinal OTC Drugs Product and Services
Table 31. Perrigo Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Perrigo Recent Developments/Updates
Table 33. Abbott Basic Information, Manufacturing Base and Competitors
Table 34. Abbott Major Business
Table 35. Abbott Gastrointestinal OTC Drugs Product and Services
Table 36. Abbott Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Abbott Recent Developments/Updates
Table 38. Sanofi Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Major Business
Table 40. Sanofi Gastrointestinal OTC Drugs Product and Services
Table 41. Sanofi Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sanofi Recent Developments/Updates
Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Major Business
Table 45. Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
Table 46. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Teva Pharmaceutical Recent Developments/Updates
Table 48. Nestle Basic Information, Manufacturing Base and Competitors
Table 49. Nestle Major Business
Table 50. Nestle Gastrointestinal OTC Drugs Product and Services
Table 51. Nestle Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Nestle Recent Developments/Updates
Table 53. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 54. Boehringer Ingelheim Major Business
Table 55. Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
Table 56. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 59. Reckitt Benckiser Major Business
Table 60. Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
Table 61. Reckitt Benckiser Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Reckitt Benckiser Recent Developments/Updates
Table 63. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Purdue Pharma Major Business
Table 65. Purdue Pharma Gastrointestinal OTC Drugs Product and Services
Table 66. Purdue Pharma Gastrointestinal OTC Drugs Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Purdue Pharma Recent Developments/Updates
Table 68. Global Gastrointestinal OTC Drugs Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 69. Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Gastrointestinal OTC Drugs Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 71. Market Position of Manufacturers in Gastrointestinal OTC Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Gastrointestinal OTC Drugs Production Site of Key Manufacturer
Table 73. Gastrointestinal OTC Drugs Market: Company Product Type Footprint
Table 74. Gastrointestinal OTC Drugs Market: Company Product Application Footprint
Table 75. Gastrointestinal OTC Drugs New Market Entrants and Barriers to Market Entry
Table 76. Gastrointestinal OTC Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 78. Global Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 79. Global Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Gastrointestinal OTC Drugs Average Price by Region (2019-2024) & (USD/Dose)
Table 82. Global Gastrointestinal OTC Drugs Average Price by Region (2025-2030) & (USD/Dose)
Table 83. Global Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 84. Global Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 85. Global Gastrointestinal OTC Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Gastrointestinal OTC Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Gastrointestinal OTC Drugs Average Price by Type (2019-2024) & (USD/Dose)
Table 88. Global Gastrointestinal OTC Drugs Average Price by Type (2025-2030) & (USD/Dose)
Table 89. Global Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 90. Global Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 91. Global Gastrointestinal OTC Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Gastrointestinal OTC Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Gastrointestinal OTC Drugs Average Price by Application (2019-2024) & (USD/Dose)
Table 94. Global Gastrointestinal OTC Drugs Average Price by Application (2025-2030) & (USD/Dose)
Table 95. North America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 96. North America Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 97. North America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 98. North America Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 99. North America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 100. North America Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 101. North America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 104. Europe Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 105. Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 106. Europe Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 107. Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 108. Europe Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 109. Europe Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 112. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 113. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 114. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 115. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 116. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 117. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 120. South America Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 121. South America Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 122. South America Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 123. South America Gastrointestinal OTC Drugs Sales Quantity by Country (2019-2024) & (K Dose)
Table 124. South America Gastrointestinal OTC Drugs Sales Quantity by Country (2025-2030) & (K Dose)
Table 125. South America Gastrointestinal OTC Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Gastrointestinal OTC Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2019-2024) & (K Dose)
Table 128. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Type (2025-2030) & (K Dose)
Table 129. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2019-2024) & (K Dose)
Table 130. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Application (2025-2030) & (K Dose)
Table 131. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Region (2019-2024) & (K Dose)
Table 132. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity by Region (2025-2030) & (K Dose)
Table 133. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Gastrointestinal OTC Drugs Raw Material
Table 136. Key Manufacturers of Gastrointestinal OTC Drugs Raw Materials
Table 137. Gastrointestinal OTC Drugs Typical Distributors
Table 138. Gastrointestinal OTC Drugs Typical Customers
LIST OF FIGURES
Figure 1. Gastrointestinal OTC Drugs Picture
Figure 2. Global Gastrointestinal OTC Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Type in 2023
Figure 4. Laxatives Examples
Figure 5. Anti-Flatulents Examples
Figure 6. H2-Antaginists Examples
Figure 7. Anti-Diarrheals Examples
Figure 8. PPIs Examples
Figure 9. Anti-Emetics Examples
Figure 10. Other Examples
Figure 11. Global Gastrointestinal OTC Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Application in 2023
Figure 13. Hospital Pharmacies Examples
Figure 14. Retail Pharmacies Examples
Figure 15. Online Pharmacies Examples
Figure 16. Global Gastrointestinal OTC Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Gastrointestinal OTC Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Gastrointestinal OTC Drugs Sales Quantity (2019-2030) & (K Dose)
Figure 19. Global Gastrointestinal OTC Drugs Average Price (2019-2030) & (USD/Dose)
Figure 20. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Gastrointestinal OTC Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Gastrointestinal OTC Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Gastrointestinal OTC Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Gastrointestinal OTC Drugs Average Price by Type (2019-2030) & (USD/Dose)
Figure 35. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Gastrointestinal OTC Drugs Average Price by Application (2019-2030) & (USD/Dose)
Figure 38. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 58. China Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Gastrointestinal OTC Drugs Market Drivers
Figure 79. Gastrointestinal OTC Drugs Market Restraints
Figure 80. Gastrointestinal OTC Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Gastrointestinal OTC Drugs in 2023
Figure 83. Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure 84. Gastrointestinal OTC Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Gastrointestinal OTC Drugs Picture
Figure 2. Global Gastrointestinal OTC Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Type in 2023
Figure 4. Laxatives Examples
Figure 5. Anti-Flatulents Examples
Figure 6. H2-Antaginists Examples
Figure 7. Anti-Diarrheals Examples
Figure 8. PPIs Examples
Figure 9. Anti-Emetics Examples
Figure 10. Other Examples
Figure 11. Global Gastrointestinal OTC Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 12. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Application in 2023
Figure 13. Hospital Pharmacies Examples
Figure 14. Retail Pharmacies Examples
Figure 15. Online Pharmacies Examples
Figure 16. Global Gastrointestinal OTC Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Gastrointestinal OTC Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Gastrointestinal OTC Drugs Sales Quantity (2019-2030) & (K Dose)
Figure 19. Global Gastrointestinal OTC Drugs Average Price (2019-2030) & (USD/Dose)
Figure 20. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Gastrointestinal OTC Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Gastrointestinal OTC Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Gastrointestinal OTC Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Gastrointestinal OTC Drugs Average Price by Type (2019-2030) & (USD/Dose)
Figure 35. Global Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Gastrointestinal OTC Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Gastrointestinal OTC Drugs Average Price by Application (2019-2030) & (USD/Dose)
Figure 38. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 58. China Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Gastrointestinal OTC Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Gastrointestinal OTC Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Gastrointestinal OTC Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Gastrointestinal OTC Drugs Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Gastrointestinal OTC Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Gastrointestinal OTC Drugs Market Drivers
Figure 79. Gastrointestinal OTC Drugs Market Restraints
Figure 80. Gastrointestinal OTC Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Gastrointestinal OTC Drugs in 2023
Figure 83. Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure 84. Gastrointestinal OTC Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
